Search Results

Displaying Results 26-50 of 10844 "'T'"

Sep 09, 2026, 09:30 ET LAFC | LINE FRIENDS Launches Exclusive Collaborative Merchandise Collection at Korean Heritage Night on September 9th

partnership to bring even more meaningful experiences to our global community."The new exclusive collection features an Adult Size T-Shirt (one style), Kids Size T-Shirt (one style), Kids Size Hoodie (one style), BROWN Classic Plush Keyring, BROWN Random Mini Keyring and heat-transfer patches (three

More news about: LINE FRIENDS


Sep 09, 2026, 09:06 ET Arrow Tool Group Becomes Diamond Sponsor for 2026 U.S. Capitol Christmas Tree

been a leader in fastening solutions across big-box home improvement stores and traditional hardware retail channels. For more than five decades, the T50® staple gun has set the industry standard as the world's best-selling staple gun, with more than 50 million sold worldwide.Today, Arrow Tool

More news about: Arrow Tool Group


Sep 09, 2026, 09:06 ET The Cheapest Way to Own a Copper Mine Is to Let Someone Else Build It

total proceeds to approximately US$87.8 million.Proven and probable reserves of 7.13 million tonnes grading 2.55 g/t gold, 47.82 g/t silver, 1.93% copper, 0.26% lead and 2.63% zinc, supporting an after-tax net present value of US$573 million at an 8% discount rate and a 45%

More news about: Canada News Group


Sep 09, 2026, 09:00 ET See What's Next: The 2027 Swanepoel Trends Report

president of media at T3 Sixty. "Every chapter ties a trend to a decision, so brokers, agents, MLSs and associations can head into 2027 with a clear view of what's ahead."Preorders are open now at t3trends.com and include the 2027 report in digital and print, access to T3 Sixty's T3 Trends research

More news about: T3 Sixty


Sep 09, 2026, 09:00 ET First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

based on native GLP-1 and designed for once-weekly administration. It is being developed for the treatment of type 2 diabetes mellitus (T2DM) and for weight management in people with obesity or overweight. GZC8072 is underpinned by two proprietary technology platforms — NovaPeptide™,

More news about: Gan & Lee Pharmaceuticals


Sep 09, 2026, 09:00 ET Meet Oregon's Next Generation of Tech Talent: Rentec Direct Awards 2026 Tech Mastery Scholarships

Oregon Institute of Technology, Oregon State University and Portland State University and have gone on to build careers at companies including Apple, AT&T, Microsoft, NASA, Netflix and Pfizer.Meet the 2026 Tech Mastery Scholarship recipients:Evan Alvarez, a graduate

More news about: Rentec Direct, LLC


Sep 09, 2026, 09:00 ET Building Together: HYUNDAI-POSCO Louisiana Steel Marks a Major Milestone, Welcomes Nearly 700 Residents to Community Day

nod to 2029, when commercial production is scheduled to begin. Participants who completed the challenge received HPLS-branded merchandise including T-shirts, caps and eco-friendly coasters.Food offered another point of connection between Louisiana and Korea, with residents enjoying local favorites

More news about: HYUNDAI-POSCO Louisiana Steel


Sep 09, 2026, 08:47 ET John T. Floyd Law Firm Consolidates Criminal Defense Practice, Adding Christopher Choate and Mia Floyd in Houston

team reflects our unwavering dedication to delivering premier, aggressive defense strategy."About John T. Floyd Law Firm: Led by widely-recognized, board-certified John T. Floyd, the legal team represents clients under investigation or charged with white-collar criminal offenses

More news about: John T. Floyd Law Firm


Sep 09, 2026, 08:42 ET Cybersecurity's Flawed Narrative Needs a Reboot: New Book Says the Human Layer Is the First Defense Against AI-Enabled Deception

for the H.I.V.E. Ecosystem:The book launches a broader H.I.V.E. ecosystem, including a forthcoming practical implementation guide by Tammy T. Scott and future resources focused on protecting families from AI deception and synthetic media fraud.H.I.V.E. Human Intelligence

More news about: Rockwell L. Scott


Sep 09, 2026, 08:35 ET Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV

lira-cel, an ovarian cancer immunotherapy being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. This technology is differentiated from other cell therapies as the natural ligand of the FSHR receptor, FSH,

More news about: Anixa Biosciences, Inc.


Sep 09, 2026, 08:31 ET Yutong lance son autocar haut de gamme T14 en Europe

gamme.Élargissement de la gamme T-SeriesGrâce à ses améliorations globales en matière de confort, d'économie d'exploitation, de systèmes intelligents et de performances du groupe motopropulseur, le T14 vient enrichir davantage la gamme de produits de la série T de Yutong, offrant ainsi un choix

More news about: Yutong


Sep 09, 2026, 08:30 ET Elmo Motion Control Titanium Line Completes Functional Safety Certification

respective owners and may or may not be trademarked.Media ContactRobert Dugan, Marketing Manager at Elmo Motion ControlT: +972-(3)-929-2300 (ext. 368)E: [email protected] 

More news about: Elmo Motion Control, Ltd.


Sep 09, 2026, 08:19 ET MYTHERESA FALL/WINTER 2026 CAMPAIGN FEATURING CHLOË SEVIGNY

https://we.tl/t-60UWn0ep6VmzEYTLMytheresa PR Contact: [email protected] 

More news about: Mytheresa


Sep 09, 2026, 08:00 ET UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA®(certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)

with immunosuppression and malignancies not usually seen in this patient population.Postmarketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers, including CIMZIA. These cases have had a very aggressive

More news about: UCB


Sep 09, 2026, 08:00 ET DJI accueille des cinéastes et des visionnaires lors d'une session au Venice Production Bridge pendant la 83e Mostra internationale du film de Venise

laquelle l'industrie commence seulement à répondre : lorsque une caméra de cinéma tient dans la paume de la main, comment le langage même du cinéma évolue‑t‑il ?

More news about: DJI


Sep 09, 2026, 07:56 ET Kapital Raises $125M in New Financing from Tru Arrow Partners, Fasanara Capital

/C O R R E C T I O N -- Kapital/ In the news release, Kapital Raises $125M in New Financing from Tru Arrow Partners, Fasanara Capital, issued Sept. 9, 2026 by Kapital over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with

More news about: Kapital


Sep 09, 2026, 07:35 ET Yutong uvádza na európsky trh prémiový turistický autokar T14

prémiový cestovný ruch.Rozšírenie modelového radu TVďaka komplexným vylepšeniam v oblasti komfortu, prevádzkovej hospodárnosti, inteligentných systémov a výkonu pohonnej jednotky model T14 ďalej obohacuje ponuku produktov Yutong radu T a poskytuje európskym zákazníkom širšiu škálu produktových

More news about: Yutong


Sep 09, 2026, 07:35 ET 43North Foundation Sets $5 Billion Economic Impact Goal for Buffalo's Next Decade

from mentors in related fields, and access to other business incentive programs. 43North operates through the support of Governor Kathy Hochul, the M&T Bank Foundation and several other sponsors. Funding for 43North program activities has been provided in part by Empire State Development. For more

More news about: 43North Foundation


Sep 09, 2026, 07:12 ET Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Solstice is advancing its lead candidate porustobart, a differentiated, second-generation, Fc-enhanced cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody, across two clinical indications, one in microsatellite-stable (MSS) colon cancer and a second, undisclosed

More news about: Harbour BioMed


Sep 09, 2026, 07:00 ET Marengo Therapeutics Completes Enrollment in Phase 1/2 STARt-001 Monotherapy Cohorts and Strengthens Leadership to Advance Invikafusp Alfa Toward Late-Stage Development

bispecific dual T-cell agonist. It is designed to selectively activate a common Vβ T-cell subset found in all cancers by combining a non-clonal mode of TCR activation with a T-cell co-stimulatory signal in a single molecule. This approach promotes the expansion of clonally diverse, effector memory Vβ T cells,

More news about: Marengo Therapeutics


Sep 09, 2026, 07:00 ET DENARIUS METALS ANNOUNCES 7 KM EXTENSION OF PROPERTY HOLDINGS AT ITS TORAL PROJECT IN NORTHERN SPAIN, INCLUDING THE FORMER PRODUCING ZN-PB ANTONINA MINE; ALSO ANNOUNCES MAIDEN NI 43-101 MINERAL RESOURCE ESTIMATE FOR THE TORAL PROJECT

US$36.30/t + processing US$18.33/t (effective after sorting) + G&A US$6.28/t = US$60.91/t, rounded to US$61/t for reporting.ZnEq% = Zn% + (Pb% × 0.7482) + (Ag g/t × 0.000248).NSR (US$/t ROM) = (Zn%/100 × 0.81 × 2,900 × 0.85) + (Pb%/100 × 0.87 × 2,020 × 0.95) + (Ag g/t × 0.49 × (37/31.1035)

More news about: Denarius Metals Corp.


Sep 09, 2026, 07:00 ET OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes

the conversion of Inferred Mineral Resources (Table 1). Notable results included 7.9 m @ 5.4 g/t Au (DDH8286), 12.0 m @ 2.3 g/t Au (DDH8298), 21.0 m @ 1.1 g/t Au (DDH8283) and 6.0 m @ 1.7 g/t Au (DDH8367), which support the emergence of a higher-grade zone plunging to the southeast (Figure 4).

More news about: OceanaGold Corporation


Sep 09, 2026, 07:00 ET OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes

the conversion of Inferred Mineral Resources (Table 1). Notable results included 7.9 m @ 5.4 g/t Au (DDH8286), 12.0 m @ 2.3 g/t Au (DDH8298), 21.0 m @ 1.1 g/t Au (DDH8283) and 6.0 m @ 1.7 g/t Au (DDH8367), which support the emergence of a higher-grade zone plunging to the southeast (Figure 4).

More news about: OceanaGold Corporation


Sep 09, 2026, 06:55 ET Yutong wprowadza na rynek europejski autokar premium T14

Europie – od przełęczy górskich po drogi nadmorskie. Dzięki temu T14 sprawdza się zarówno w międzynarodowych przewozach dalekobieżnych, jak i w segmencie turystyki premium.Rozszerzenie serii TT14 rozszerza serię T Yutong o model zmodernizowany pod kątem komfortu, ekonomiki eksploatacji,

More news about: Yutong


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.